Topical Agent for Treatment of Red Skin
Completed · Phase 1
Conditions studied: Rosacea, Bilaterally Symmetric Red Skin on Cheeks
In brief
SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety
Key facts
- Study ID
- NCT00279890
- Run by
- Mayo Clinic
- People needed
- 20
- Starts
- 2005-07-01
- Expected to finish
- 2007-01-01
- Last updated by the study team
- 2011-05-23
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.